Marta Guerrero
Overview
Explore the profile of Marta Guerrero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sacristan C, Guerrero M, Sanchez S, Rodriguez A, Garcia R, Ewbank A, et al.
Arch Environ Contam Toxicol
. 2024 Dec;
88(1):97-109.
PMID: 39645540
Fertilization with animal manure and sewage sludge, and the use of sewage water for irrigation, can lead to high antimicrobial concentrations in agricultural soils. Once in soil, antimicrobials can exert...
2.
Rubio Maturana C, Guerrero M, Casas Claramunt M, Ayala-Cortes S, Lopez V, Martinez-Vallejo P, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2024 Jun;
43(3):139-147.
PMID: 38902155
Introduction: Almost 281 million people were living in a foreign country in 2022, and more than 100 million were displaced because of war conflicts and human right violations. Vaccination coverage...
3.
San Martin-Lopez J, Mesa N, Bernal-Bello D, Morales-Ortega A, Rivilla M, Guerrero M, et al.
Viruses
. 2023 Sep;
15(9).
PMID: 37766248
(1) Background: COVID-19 has evolved during seven epidemic waves in Spain. Our objective was to describe changes in mortality and severity in our hospitalized patients. (2) Method: This study employed...
4.
Rodriguez-Peralvarez M, Gomez-Orellana A, Majumdar A, Bailey M, McCaughan G, Gow P, et al.
Lancet Gastroenterol Hepatol
. 2022 Dec;
8(3):242-252.
PMID: 36528041
Background: The Model for End-stage Liver Disease (MELD) and its sodium-corrected variant (MELD-Na) have created gender disparities in accessing liver transplantation. We aimed to derive and validate the Gender-Equity Model...
5.
Ruiz-Giardin J, Rivilla M, Mesa N, Morales A, Rivas L, Izquierdo A, et al.
Viruses
. 2022 Oct;
14(10).
PMID: 36298839
Objectives: This study aimed to compare the characteristics of fully and partially vaccinated or unvaccinated coronavirus disease 2019 (COVID-19) patients who were hospitalised in a population of 220,000 habitants. Methods:...
6.
Llovet L, Gratacos-Gines J, Tellez L, Gomez-Outomuro A, Navascues C, Riveiro-Barciela M, et al.
Hepatol Commun
. 2022 Jan;
6(6):1392-1402.
PMID: 34989164
The value of noninvasive tools in the diagnosis of autoimmune hepatitis (AIH)-related cirrhosis and the prediction of clinical outcomes is largely unknown. We sought to evaluate (1) the utility of...
7.
Gala A, Guerrero M, Serra J
Waste Manag
. 2020 May;
111:22-33.
PMID: 32470724
The purpose of this paper is to provide a full characterization of post-consumer plastic film recovered from mixed municipal solid waste (MSW) treatment plants in Spain. Currently, this type of...
8.
Ferrin G, Guerrero M, Amado V, Rodriguez-Peralvarez M, Mata M
Int J Mol Sci
. 2020 Feb;
21(4).
PMID: 32070029
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and occurs mainly in patients with liver cirrhosis. The mammalian target of rapamycin (mTOR) signaling pathway is involved in many...
9.
Rodriguez-Peralvarez M, Guerrero M, De Luca L, Gros B, Thorburn D, Patch D, et al.
Transplantation
. 2019 May;
103(12):2539-2548.
PMID: 31107827
Background: Tacrolimus minimization is usually restricted to patients with pretransplant renal impairment, and this strategy could result into worse renal outcomes after liver transplantation (LT). Methods: A consecutive cohort of...
10.
Guerrero M, Ferrin G, Rodriguez-Peralvarez M, Gonzalez-Rubio S, Sanchez-Frias M, Amado V, et al.
Int J Mol Sci
. 2019 Jan;
20(2).
PMID: 30650598
(1) Background: The mammalian target of rapamycin (mTOR) pathway activation is critical for hepatocellular carcinoma (HCC) progression. We aimed to evaluate the mTOR tissue expression in liver transplant (LT) patients...